GlobeNewswire by notified

NNIT A/S: Disclosure of corrective information to NNIT’s annual report for 2021, including comparative numbers for 2020

Share

With reference to company announcement 2/2023, stating the Danish Business Authority’s final decision on NNIT’s accounting treatment of an earn out payment related to the acquisition of Excellis Health Solutions, NNIT hereby publishes supplemental/corrective information to the annual report for 2021, including comparative numbers for 2020.

The technical changes to historical accounting policies have no impact on total cash flow or the planned divestment of NNIT’s Infrastructure Operations Business.

As previously stated, NNIT A/S disagrees with the decision and considers it to be of principled nature for strategic acquisitions in the Danish IT service industry. NNIT has strong arguments as to why this is an erroneous decision, and an appeal of the decision has been lodged to the Danish Commerce and Companies Appeals Board. The average processing time for appeals is currently 5 months.

Contact for further information

Carsten Ringius
EVP & CFO
Tel: +45 3077 8888
carr@nnit.com

Media relations:
Tina Joanne Hindsbo
Media Relations Manager
Tel: +45 3077 9578
tnjh@nnit.com

The NNIT Group provides a wide range of IT and consulting services internationally. In Denmark, where the Group HQ is based, we are one of the leading IT companies, servicing both private and public sector customers across all industries. In the rest of Europe, Asia and USA, we are solely focused on companies within life sciences.

Supporting the entire supply chain, we help optimize internal company processes, production, sales and customer experiences:

We advise, build, operate and support, enabling digital transformation and customers to reap the full potential of their organizations. Our role is to foster innovation and make the mark our customers and we aspire to.

The NNIT Group consists of group company NNIT A/S and subsidiaries SCALES, Excellis Health Solutions and SL Controls. Read more at www.nnit.com.


Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

SHARE BUYBACK TRANSACTIONS6.5.2024 10:30:00 CEST | Press release

COMPANY ANNOUNCEMENT no. 34 - 6 May 2024 On 9 February 2024, DFDS A/S (“DFDS”) announced the initiation of a share buyback programme to be executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014, and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”). Under the programme, DFDS will repurchase own shares of up to DKK 431m during the period from 12 February 2024 to 31 December 2024. A maximum of 3,400,000 shares will be repurchased. These limits include shares purchased under the Safe Harbour rules as well as shares purchased from Lauritzen Fonden Holding ApS on a pro rata basis to the shares purchased in the programme under a separate agreement with DFDS outside the Safe Harbour Rules. Transactions 29 April-3 May The following transactions have been made under the share buyback programme from Monday 29 April 2024 to Friday 3 May 2024: Number of sharesAvg. purchase price (DKK)Transaction

AKTIETILBAGEKØBSHANDLER6.5.2024 10:30:00 CEST | pressemeddelelse

SELSKABSMEDDELELSE nr. 34 - 6. maj 2024 Den 9. februar 2024 meddelte DFDS A/S (“DFDS”) iværksættelsen af et aktietilbage-købsprogram til gennemførsel i henhold til EUs markedsmisbrugsforordning, EU forordning nr. 596/2014 af 16. april 2014, samt EU-Kommissionens delegerede forordning (EU) nr. 2016/1052 af 8. marts 2016 (”Safe Harbour-reglerne”). Under programmet vil DFDS tilbagekøbe egne aktier for op til DKK 431 mio. i perioden fra 12. februar 2024 til 31. december 2024. Der vil maksimalt blive tilbagekøbt 3.400.000 aktier. Disse begrænsninger omfatter såvel aktier købt under Safe Harbour-reglerne som aktier købt fra Lauritzen Fonden Holding ApS på en pro rata basis i forhold til aktier købt under programmet i henhold til en separat aftale med DFDS udenfor Safe Harbour-reglerne. Handler i perioden 29. april-3. maj De følgende handler er gennemført under aktietilbagekøbsprogrammet i perioden mandag 29. april 2024 til fredag 3. maj 2024: Antal aktierGns. Købspris (DKK)Handelsværdi (DKK)

Curium Announces First Commercial Doses in Germany of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer6.5.2024 10:25:06 CEST | Press release

PARIS, May 06, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that today in Munich and Nurnberg, Germany the first commercial doses of PYLCLARI® have been delivered. PYLCLARI® (INN: Piflufolastat (18F) also known as (18F)-DCFPyL), is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in patients with prostate cancer in the following clinical settings: Primary staging of patients with high-risk prostate cancer prior to initial curative therapyTo localize recurrence of prostate cancer in patients with a suspected recurrence based on increasing serum prostate-specific antigen (PSA) levels after primary treatment with curative intent Benoit Woessmer, PET Europe CEO at Curium commented, “We are pleased with the growing availability of PYLCLARI® to more nuclear medicine physicians and their patients across Europe. With today’s announcement, we are extremely proud to be improving the

Correction: Aktietilbagekøbsprogram - uge 186.5.2024 10:12:52 CEST | pressemeddelelse

Korrektion: Antal aktier og procent af aktiekapital under tabellen var fejlbehæftet. Nasdaq Copenhagen London Stock Exchange Euronext Dublin Øvrige interessenter Dato 06.05.2024 Aktietilbagekøbsprogram - uge 18 Aktietilbagekøbsprogrammet løber i perioden fra og med den 1. februar 2024 og til og med den 27. januar 2025 - fordelt på del I med DKK 750 mio. og maksimalt 1.500.000 stk. aktier til effektuering i perioden 1. februar 2024 -28. juni 2024 samt del II med DKK 775 mio. og maksimalt 1.550.000 stk. aktier til effektuering i perioden 1. juli 2024 - 27. januar 2025, jf. selskabsmeddelelse af 31. januar 2024. Programmet gennemføres i henhold til EU-Kommissionens forordning nr. 596/2014 af 16. april 2014 og EU-Kommissionens delegerede forordning nr. 2016/1052 af 8. marts 2016, der tilsammen udgør ”Safe Harbour”-reguleringen. Følgende transaktioner er foretaget under aktietilbagekøbsprogrammet: DatoAntal aktier (stk.)Gennemsnitlig købspris (kroner)Tilbagekøbt i alt under programmet (kron

Correction: Share buy-back programme - week 186.5.2024 10:12:52 CEST | Press release

Correction: Number of shares and percentage of share capital under the table was incorrect. Nasdaq Copenhagen London Stock Exchange Euronext Dublin Other stakeholders Date 06.05.2024 Share buy-back programme - week 18 The share buy-back programme runs in the period 1 February 2024 up to and including 27 January 2025. Part I of the programme, for DKK 750 million and a maximum of 1,500,000 shares, is for execution in the period 1 February 2024 - 28 June 2024 and part II of the programme, for DKK 775 million and a maximum of 1,550,000 shares, is for execution in the period 1 July 2024 - 27 January 2025, see company announcement of 31 January 2024. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the programme: DateNumber of sharesAverage purchase price (DKK)Total

HiddenA line styled icon from Orion Icon Library.Eye